Adverse drug events in cost-effectiveness models of pharmacological interventions for diabetes, diabetic retinopathy, and diabetic macular edema: a scoping review.
Article in JBI Evidence Synthesis (July 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Bibliometric analysis of research on the utilization of nanotechnology in diabetes mellitus and its complications
Article in Nanomedicine (July 2024)
Cost-effectiveness of Finerenone in Addition to Standard of Care for Patients with Chronic Kidney Disease and Type 2 Diabetes in China
Article in Advances in Therapy (June 2024)